Chen Zhefan Stephen, Peng Shaohong Isaac, Leong Lok I, Gall-Duncan Terence, Wong Nathan Siu Jun, Li Tsz Ho, Lin Xiao, Wei Yuming, Koon Alex Chun, Huang Junzhe, Sun Jacquelyne Ka-Li, Turner Clinton, Tippett Lynette, Curtis Maurice A, Faull Richard L M, Kwan Kin Ming, Chow Hei-Man, Ko Ho, Chan Ting-Fung, Talbot Kevin, Pearson Christopher E, Chan Ho Yin Edwin
School of Life Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Gerald Choa Neuroscience Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.
Nat Commun. 2025 Apr 9;16(1):3307. doi: 10.1038/s41467-025-58618-4.
MicroRNAs (miRNAs) are small non-coding RNAs that play crucial roles in post-transcriptional gene regulation. Poly(A) RNA polymerase D5 (PAPD5) catalyzes the addition of adenosine to the 3' end of miRNAs. In this study, we demonstrate that the Yin Yang 1 protein, a transcriptional repressor of PAPD5, is recruited to both RNA foci and protein aggregates, resulting in an upregulation of PAPD5 expression in Huntington's disease (HD). Additionally, we identify a subset of PAPD5-regulated miRNAs with increased adenylation and reduced expression in our disease model. We focus on miR-7-5p and find that its reduction causes the activation of the TAB2-mediated TAK1-MKK4-JNK pro-apoptotic pathway. This pathway is also activated in induced pluripotent stem cell-derived striatal neurons and post-mortem striatal tissues isolated from HD patients. In addition, we discover that a small molecule PAPD5 inhibitor, BCH001, can mitigate cell death and neurodegeneration in our disease models. This study highlights the importance of PAPD5-mediated miRNA dysfunction in HD pathogenesis and suggests a potential therapeutic direction for the disease.
微小RNA(miRNA)是一类小的非编码RNA,在转录后基因调控中发挥关键作用。聚腺苷酸(Poly(A))RNA聚合酶D5(PAPD5)催化腺苷添加到miRNA的3'末端。在本研究中,我们证明阴阳1蛋白(一种PAPD5的转录抑制因子)被募集到RNA病灶和蛋白质聚集体中,导致亨廷顿舞蹈病(HD)中PAPD5表达上调。此外,我们在我们的疾病模型中鉴定出一组PAPD5调控的miRNA,其腺苷化增加且表达降低。我们聚焦于miR-7-5p,发现其表达降低会导致TAB2介导的TAK1-MKK4-JNK促凋亡途径的激活。该途径在诱导多能干细胞衍生的纹状体神经元和从HD患者分离的死后纹状体组织中也被激活。此外,我们发现一种小分子PAPD5抑制剂BCH001可以减轻我们疾病模型中的细胞死亡和神经退行性变。本研究突出了PAPD5介导的miRNA功能障碍在HD发病机制中的重要性,并为该疾病提出了一个潜在的治疗方向。